Microbix Biosystems Inc. (MBX.TO)
CAD 0.36
(-5.26%)
CAD 0.36
(-5.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.75 Million CAD | 8.84% |
| 2022 | 5.28 Million CAD | 19.91% |
| 2021 | 4.4 Million CAD | 2.68% |
| 2020 | 4.29 Million CAD | -4.19% |
| 2019 | 4.48 Million CAD | 0.75% |
| 2018 | 4.44 Million CAD | -0.45% |
| 2017 | 4.46 Million CAD | 31.54% |
| 2016 | 3.39 Million CAD | -6.32% |
| 2015 | 3.62 Million CAD | 126.8% |
| 2014 | 1.59 Million CAD | 49.09% |
| 2013 | 1.07 Million CAD | -14.04% |
| 2012 | 1.24 Million CAD | -2.86% |
| 2011 | 1.28 Million CAD | 17.64% |
| 2010 | 1.09 Million CAD | 16.81% |
| 2009 | 934.37 Thousand CAD | 7.94% |
| 2008 | 865.63 Thousand CAD | 14.41% |
| 2007 | 756.57 Thousand CAD | -10.34% |
| 2006 | 843.79 Thousand CAD | 51.89% |
| 2005 | 555.52 Thousand CAD | 12.94% |
| 2004 | 491.87 Thousand CAD | 8.83% |
| 2003 | 451.95 Thousand CAD | 5.28% |
| 2002 | 429.28 Thousand CAD | 9.96% |
| 2001 | 390.4 Thousand CAD | -4.9% |
| 2000 | 410.53 Thousand CAD | 2.63% |
| 1999 | 400 Thousand CAD | -87.1% |
| 1998 | 3.1 Million CAD | 416.67% |
| 1997 | 600 Thousand CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 6.15 Million CAD | 0.21% |
| 2024 Q3 | 6.24 Million CAD | 1.49% |
| 2024 Q1 | 6.14 Million CAD | 6.82% |
| 2023 FY | 5.75 Million CAD | 8.84% |
| 2023 Q1 | 6.08 Million CAD | 15.18% |
| 2023 Q2 | 6.85 Million CAD | 12.6% |
| 2023 Q4 | 5.75 Million CAD | -4.93% |
| 2023 Q3 | 6.05 Million CAD | -11.72% |
| 2022 Q1 | 4.85 Million CAD | 10.05% |
| 2022 Q4 | 5.28 Million CAD | -0.26% |
| 2022 FY | 5.28 Million CAD | 19.91% |
| 2022 Q2 | 5.34 Million CAD | 10.15% |
| 2022 Q3 | 5.29 Million CAD | -0.82% |
| 2021 Q2 | 4.91 Million CAD | 8.51% |
| 2021 Q3 | 4.82 Million CAD | -1.86% |
| 2021 Q1 | 4.52 Million CAD | 5.51% |
| 2021 FY | 4.4 Million CAD | 2.68% |
| 2021 Q4 | 4.4 Million CAD | -8.61% |
| 2020 Q4 | 4.29 Million CAD | -11.22% |
| 2020 FY | 4.29 Million CAD | -4.19% |
| 2020 Q3 | 4.83 Million CAD | 0.93% |
| 2020 Q2 | 4.79 Million CAD | -0.39% |
| 2020 Q1 | 4.8 Million CAD | 7.35% |
| 2019 FY | 4.48 Million CAD | 0.75% |
| 2019 Q1 | 5.32 Million CAD | 19.72% |
| 2019 Q2 | 5.22 Million CAD | -1.94% |
| 2019 Q4 | 4.48 Million CAD | -16.08% |
| 2019 Q3 | 5.33 Million CAD | 2.26% |
| 2018 Q2 | 4.61 Million CAD | -0.46% |
| 2018 Q4 | 4.44 Million CAD | -5.43% |
| 2018 FY | 4.44 Million CAD | -0.45% |
| 2018 Q1 | 4.64 Million CAD | 3.89% |
| 2018 Q3 | 4.7 Million CAD | 1.8% |
| 2017 FY | 4.46 Million CAD | 31.54% |
| 2017 Q4 | 4.46 Million CAD | 1.15% |
| 2017 Q3 | 4.41 Million CAD | 11.24% |
| 2017 Q2 | 3.97 Million CAD | 8.05% |
| 2017 Q1 | 3.67 Million CAD | 8.2% |
| 2016 Q4 | 3.39 Million CAD | -4.98% |
| 2016 FY | 3.39 Million CAD | -6.32% |
| 2016 Q1 | 4.01 Million CAD | 10.88% |
| 2016 Q2 | 3.66 Million CAD | -8.89% |
| 2016 Q3 | 3.57 Million CAD | -2.42% |
| 2015 Q1 | 1.65 Million CAD | 3.29% |
| 2015 Q3 | 2.43 Million CAD | 27.17% |
| 2015 Q2 | 1.91 Million CAD | 16.21% |
| 2015 FY | 3.62 Million CAD | 126.8% |
| 2015 Q4 | 3.62 Million CAD | 48.59% |
| 2014 Q3 | 1.39 Million CAD | 27.24% |
| 2014 Q4 | 1.59 Million CAD | 14.45% |
| 2014 Q2 | 1.09 Million CAD | 9.67% |
| 2014 FY | 1.59 Million CAD | 49.09% |
| 2014 Q1 | 1 Million CAD | -6.65% |
| 2013 Q4 | 1.07 Million CAD | -14.43% |
| 2013 Q1 | 1.45 Million CAD | 16.3% |
| 2013 FY | 1.07 Million CAD | -14.04% |
| 2013 Q2 | 1.34 Million CAD | -7.47% |
| 2013 Q3 | 1.25 Million CAD | -6.65% |
| 2012 Q4 | 1.24 Million CAD | -26.07% |
| 2012 FY | 1.24 Million CAD | -2.86% |
| 2012 Q3 | 1.68 Million CAD | 3.83% |
| 2012 Q2 | 1.62 Million CAD | -4.65% |
| 2012 Q1 | 1.7 Million CAD | 32.72% |
| 2011 Q1 | 1.33 Million CAD | 22.59% |
| 2011 FY | 1.28 Million CAD | 17.64% |
| 2011 Q4 | 1.28 Million CAD | -12.48% |
| 2011 Q3 | 1.46 Million CAD | 7.89% |
| 2011 Q2 | 1.35 Million CAD | 1.64% |
| 2010 FY | 1.09 Million CAD | 16.81% |
| 2010 Q4 | 1.09 Million CAD | -15.34% |
| 2010 Q2 | 1.16 Million CAD | -1.36% |
| 2010 Q3 | 1.28 Million CAD | 10.49% |
| 2010 Q1 | 1.18 Million CAD | 26.6% |
| 2009 Q3 | 798.18 Thousand CAD | 2.25% |
| 2009 Q4 | 934.37 Thousand CAD | 17.06% |
| 2009 Q1 | 780.63 Thousand CAD | -9.82% |
| 2009 FY | 934.37 Thousand CAD | 7.94% |
| 2009 Q2 | 780.63 Thousand CAD | 0.0% |
| 2008 Q4 | 865.63 Thousand CAD | -0.17% |
| 2008 Q2 | 810.28 Thousand CAD | 4.51% |
| 2008 Q1 | 775.34 Thousand CAD | 2.48% |
| 2008 FY | 865.63 Thousand CAD | 14.41% |
| 2008 Q3 | 867.12 Thousand CAD | 7.02% |
| 2007 Q4 | 756.57 Thousand CAD | -22.69% |
| 2007 Q1 | 900.02 Thousand CAD | 6.66% |
| 2007 FY | 756.57 Thousand CAD | -10.34% |
| 2007 Q2 | 954.39 Thousand CAD | 6.04% |
| 2007 Q3 | 978.67 Thousand CAD | 2.54% |
| 2006 FY | 843.79 Thousand CAD | 51.89% |
| 2006 Q4 | 843.79 Thousand CAD | 18.13% |
| 2006 Q3 | 714.29 Thousand CAD | 9.3% |
| 2006 Q2 | 653.52 Thousand CAD | 13.55% |
| 2006 Q1 | 575.52 Thousand CAD | 3.6% |
| 2005 Q4 | 555.52 Thousand CAD | 19.26% |
| 2005 Q3 | 465.8 Thousand CAD | 8.46% |
| 2005 Q2 | 429.45 Thousand CAD | -3.0% |
| 2005 Q1 | 442.73 Thousand CAD | -9.99% |
| 2005 FY | 555.52 Thousand CAD | 12.94% |
| 2004 Q4 | 491.87 Thousand CAD | -14.81% |
| 2004 FY | 491.87 Thousand CAD | 8.83% |
| 2004 Q1 | 431.95 Thousand CAD | -4.43% |
| 2004 Q2 | 507.51 Thousand CAD | 17.49% |
| 2004 Q3 | 577.37 Thousand CAD | 13.76% |
| 2003 Q2 | 466.38 Thousand CAD | -11.06% |
| 2003 Q4 | 451.95 Thousand CAD | 2.83% |
| 2003 Q3 | 439.5 Thousand CAD | -5.76% |
| 2003 FY | 451.95 Thousand CAD | 5.28% |
| 2003 Q1 | 524.41 Thousand CAD | 22.16% |
| 2002 Q1 | 438.05 Thousand CAD | 12.21% |
| 2002 FY | 429.28 Thousand CAD | 9.96% |
| 2002 Q2 | 415.64 Thousand CAD | -5.12% |
| 2002 Q3 | 374.98 Thousand CAD | -9.78% |
| 2002 Q4 | 429.28 Thousand CAD | 14.48% |
| 2001 FY | 390.4 Thousand CAD | -4.9% |
| 2001 Q4 | 390.4 Thousand CAD | 1.22% |
| 2001 Q3 | 385.71 Thousand CAD | -1.82% |
| 2001 Q2 | 392.85 Thousand CAD | 0.71% |
| 2001 Q1 | 390.09 Thousand CAD | -4.98% |
| 2000 Q3 | 400 Thousand CAD | -20.0% |
| 2000 Q2 | 500 Thousand CAD | 25.0% |
| 2000 Q1 | 400 Thousand CAD | 0.0% |
| 2000 FY | 410.53 Thousand CAD | 2.63% |
| 2000 Q4 | 410.53 Thousand CAD | 2.63% |
| 1999 Q1 | 3.1 Million CAD | 0.0% |
| 1999 Q3 | 3.1 Million CAD | 0.0% |
| 1999 Q2 | 3.1 Million CAD | 0.0% |
| 1999 Q4 | 400 Thousand CAD | -87.1% |
| 1999 FY | 400 Thousand CAD | -87.1% |
| 1998 Q2 | 800 Thousand CAD | -11.11% |
| 1998 Q1 | 900 Thousand CAD | 50.0% |
| 1998 FY | 3.1 Million CAD | 416.67% |
| 1998 Q4 | 3.1 Million CAD | 181.82% |
| 1998 Q3 | 1.1 Million CAD | 37.5% |
| 1997 Q2 | 400 Thousand CAD | 0.0% |
| 1997 Q3 | 400 Thousand CAD | 0.0% |
| 1997 Q4 | 600 Thousand CAD | 50.0% |
| 1997 Q1 | - CAD | 0.0% |
| 1997 FY | 600 Thousand CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Appili Therapeutics Inc. | - CAD | -Infinity% |
| Eupraxia Pharmaceuticals Inc. | 1.00 CAD | -575203000.0% |
| Helix BioPharma Corp. | - CAD | -Infinity% |
| Medicenna Therapeutics Corp. | - CAD | -Infinity% |
| Satellos Bioscience Inc. | -583 Thousand CAD | 1086.626% |
| Oncolytics Biotech Inc. | - CAD | -Infinity% |
| Sernova Corp. | - CAD | -Infinity% |